Search research articles
Contact Us
Filters
Showing results (101-110 of 165) with videos related to
Page
of 17
Sort By:
Virchows Archiv : an International Journal of Pathology
|
June 22, 2023
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
Karina Malmros, Andreas Lindholm, Halla Vidarsdottir, et al.
Medcomm
|
November 20, 2024
The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells
Gemma Garcia-Vicién, Núria Ruiz, Patrick Micke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 14, 2018
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle
Kristina Westerlund, Mohamed Altai, Bogdan Mitran, et al.
Ebiomedicine
|
April 25, 2026
Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironment
Anastasia Magoulopoulou, Maria Chatzinikolaou, Andreas Metousis, et al.
Cancer Research
|
March 18, 2010
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer
Roy-Akira Saito, Patrick Micke, Janna Paulsson, et al.
BMC Cancer
|
November 26, 2014
1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
Markus Mayrhofer, Hanna Göransson Kultima, Helgi Birgisson, et al.
Plos One
|
November 8, 2017
Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer
Verena Jabs, Karolina Edlund, Helena König, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 11, 2021
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation
Pablo Moreno-Ruiz, Sara Corvigno, Nienke C Te Grootenhuis, et al.
Plos One
|
June 27, 2009
Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data
Hanna Göransson, Karolina Edlund, Maria Rydåker, et al.
BJU International
|
June 16, 2009
A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer
M Ulrika Segersten, E Karolina Edlund, Patrick Micke, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 165) with videos related to
Sort By:
Page
of 17
Virchows Archiv : an International Journal of Pathology
|
June 22, 2023
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
Karina Malmros, Andreas Lindholm, Halla Vidarsdottir, et al.
Medcomm
|
November 20, 2024
The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells
Gemma Garcia-Vicién, Núria Ruiz, Patrick Micke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 14, 2018
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle
Kristina Westerlund, Mohamed Altai, Bogdan Mitran, et al.
Ebiomedicine
|
April 25, 2026
Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironment
Anastasia Magoulopoulou, Maria Chatzinikolaou, Andreas Metousis, et al.
Cancer Research
|
March 18, 2010
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer
Roy-Akira Saito, Patrick Micke, Janna Paulsson, et al.
BMC Cancer
|
November 26, 2014
1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
Markus Mayrhofer, Hanna Göransson Kultima, Helgi Birgisson, et al.
Plos One
|
November 8, 2017
Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer
Verena Jabs, Karolina Edlund, Helena König, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 11, 2021
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation
Pablo Moreno-Ruiz, Sara Corvigno, Nienke C Te Grootenhuis, et al.
Plos One
|
June 27, 2009
Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data
Hanna Göransson, Karolina Edlund, Maria Rydåker, et al.
BJU International
|
June 16, 2009
A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer
M Ulrika Segersten, E Karolina Edlund, Patrick Micke, et al.
Page
of 17